Literature DB >> 18159515

Enhanced surveillance of non-O157 verotoxin-producing Escherichia coli in human stool samples from Manitoba.

Laura H Thompson1, Sandra Giercke, Carole Beaudoin, David Woodward, John L Wylie.   

Abstract

BACKGROUND: Relatively few enhanced surveillance studies have been undertaken to investigate the extent to which verotoxin-producing non-O157 serotypes of Escherichia coli occur in stool samples received for the detection of verotoxin-producing organisms.
OBJECTIVES: To describe the prevalence, molecular and epidemiological characteristics, and geographical patterns associated with non-O157 verotoxin-producing E coli (VTEC) in Manitoba.
RESULTS: Thirty-two VTEC isolates consisting of 10 serogroups and 13 different serotypes were isolated over a 22-month period. Twenty-three isolates (71.8%) possessed verotoxin-encoding gene stx1 only, five isolates (15.6%) possessed stx2 only, two isolates (6.3%) possessed both stx1 and stx2, and two isolates (6.3%) possessed stx2c. Only three instances of indistinguishable pulsed-field gel electrophoresis patterns were identified. The age of the individuals from whom non-O157 VTEC were isolated ranged from eight months to 87 years. Mean and median ages were 30 and 22 years of age, respectively. Some areas of the province appeared to experience a higher than expected number of non-O157 E coli in comparison with the number of stools that were received from these areas.
CONCLUSIONS: The present study demonstrated a large number of infections associated with non-O157 VTEC in Manitoba. Most non-O157 cases appear to result from sporadic infections, and these occur typically in rural areas. Continued enhanced surveillance is necessary to understand the temporal patterns of non-O157 VTEC and the underlying epidemiological factors driving these patterns.

Entities:  

Keywords:  E coli; Epidemiology; Non-O157; Surveillance; Verotoxin

Year:  2005        PMID: 18159515      PMCID: PMC2095001          DOI: 10.1155/2005/859289

Source DB:  PubMed          Journal:  Can J Infect Dis Med Microbiol        ISSN: 1712-9532            Impact factor:   2.471


  18 in total

1.  Strong association between shiga toxin-producing Escherichia coli O157 and virulence genes stx2 and eae as possible explanation for predominance of serogroup O157 in patients with haemolytic uraemic syndrome.

Authors:  D Werber; A Fruth; U Buchholz; R Prager; M H Kramer; A Ammon; H Tschäpe
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-11-12       Impact factor: 3.267

2.  Verotoxin-producing Escherichia coli in Spain: prevalence, serotypes, and virulence genes of O157:H7 and non-O157 VTEC in ruminants, raw beef products, and humans.

Authors:  Jorge Blanco; Miguel Blanco; Jesus E Blanco; Azucena Mora; Enrique A González; Maria I Bernárdez; Maria P Alonso; Amparo Coira; Asuncion Rodriguez; Joaquin Rey; Juan M Alonso; Miguel A Usera
Journal:  Exp Biol Med (Maywood)       Date:  2003-04

3.  Clinical isolates of non-O157 Shiga toxin-producing Escherichia coli: serotypes, virulence characteristics, and molecular profiles of strains of the same serotype.

Authors:  M Eklund; F Scheutz; A Siitonen
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

4.  Prevalence and genetic profiling of virulence determinants of non-O157 Shiga toxin-producing Escherichia coli isolated from cattle, beef, and humans, Calcutta, India.

Authors:  Asis Khan; Shinji Yamasaki; Toshio Sato; Thandavarayan Ramamurthy; Amit Pal; Simanti Datta; Nandini Roy Chowdhury; Suresh Chandra Das; Asim Sikdar; Teizo Tsukamoto; Sujit Kumar Bhattacharya; Yoshifumi Takeda; Gopinath Balakrish Nair
Journal:  Emerg Infect Dis       Date:  2002-01       Impact factor: 6.883

5.  Evaluating cluster alarms: a space-time scan statistic and brain cancer in Los Alamos, New Mexico.

Authors:  M Kulldorff; W F Athas; E J Feurer; B A Miller; C R Key
Journal:  Am J Public Health       Date:  1998-09       Impact factor: 9.308

6.  Clinical Escherichia coli strains carrying stx genes: stx variants and stx-positive virulence profiles.

Authors:  Marjut Eklund; Kirsikka Leino; Anja Siitonen
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

7.  Shiga toxin-producing Escherichia coli in Montana: bacterial genotypes and clinical profiles.

Authors:  Jill K Jelacic; Todd Damrow; Gilbert S Chen; Srdjan Jelacic; Martina Bielaszewska; Marcia Ciol; Humberto M Carvalho; Angela R Melton-Celsa; Alison D O'Brien; Phillip I Tarr
Journal:  J Infect Dis       Date:  2003-08-15       Impact factor: 5.226

8.  Comparative pathogenicity of Escherichia coli O157 and intimin-negative non-O157 Shiga toxin-producing E coli strains in neonatal pigs.

Authors:  Evelyn A Dean-Nystrom; Angela R Melton-Celsa; Joachim F L Pohlenz; Harley W Moon; Alison D O'Brien
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

9.  Vero response to a cytotoxin of Escherichia coli.

Authors:  J Konowalchuk; J I Speirs; S Stavric
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

10.  Prevalence of non-O157:H7 shiga toxin-producing Escherichia coli in diarrheal stool samples from Nebraska.

Authors:  P D Fey; R S Wickert; M E Rupp; T J Safranek; S H Hinrichs
Journal:  Emerg Infect Dis       Date:  2000 Sep-Oct       Impact factor: 6.883

View more
  14 in total

1.  Non-O157 verotoxigenic Escherichia coli and beef: a Canadian perspective.

Authors:  Alexander Gill; Colin O Gill
Journal:  Can J Vet Res       Date:  2010-07       Impact factor: 1.310

2.  Evaluation of a new chromogenic agar medium for detection of Shiga toxin-producing Escherichia coli (STEC) and relative prevalences of O157 and non-O157 STEC in Manitoba, Canada.

Authors:  J L Wylie; P Van Caeseele; M W Gilmour; D Sitter; C Guttek; S Giercke
Journal:  J Clin Microbiol       Date:  2012-11-21       Impact factor: 5.948

3.  Prevalence of diarrhea-associated virulence genes and genetic diversity in Escherichia coli isolates from fecal material of various animal hosts.

Authors:  Abhirosh Chandran; Asit Mazumder
Journal:  Appl Environ Microbiol       Date:  2013-09-20       Impact factor: 4.792

4.  Comparison of clinical and epidemiological features of Shiga toxin-producing Escherichia coli O157 and non-O157 infections in British Columbia, 2009 to 2011.

Authors:  Xuetao Wang; Marsha Taylor; Linda Hoang; Judi Ekkert; Craig Nowakowski; Jason Stone; Greg Tone; Steven Trerise; Ana Paccagnella; Titus Wong; Eleni Galanis
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

5.  Occurrence of potentially human-pathogenic Escherichia coli O103 in Norwegian sheep.

Authors:  Camilla Sekse; Marianne Sunde; Petter Hopp; Torkjel Bruheim; Kofitsyo Sewornu Cudjoe; Bjørg Kvitle; Anne Margrete Urdahl
Journal:  Appl Environ Microbiol       Date:  2013-09-27       Impact factor: 4.792

6.  Molecular characterization reveals three distinct clonal groups among clinical shiga toxin-producing Escherichia coli strains of serogroup O103.

Authors:  Atsushi Iguchi; Sunao Iyoda; Makoto Ohnishi
Journal:  J Clin Microbiol       Date:  2012-06-20       Impact factor: 5.948

7.  Comparison of Shiga toxin-producing Escherichia coli detection methods using clinical stool samples.

Authors:  Linda Chui; Marc R Couturier; Theodore Chiu; Gehua Wang; Adam B Olson; Ryan R McDonald; Nick A Antonishyn; Greg Horsman; Matthew W Gilmour
Journal:  J Mol Diagn       Date:  2010-05-13       Impact factor: 5.568

8.  Shiga-toxigenic Escherichia coli detection in stool samples screened for viral gastroenteritis in Alberta, Canada.

Authors:  Marc Roger Couturier; Bonita Lee; Nathan Zelyas; Linda Chui
Journal:  J Clin Microbiol       Date:  2010-12-08       Impact factor: 5.948

9.  Pathogenic potential, genetic diversity, and population structure of Escherichia coli strains isolated from a forest-dominated watershed (Comox Lake) in British Columbia, Canada.

Authors:  Abhirosh Chandran; Asit Mazumder
Journal:  Appl Environ Microbiol       Date:  2014-12-29       Impact factor: 4.792

10.  Sequence-based typing of genetic targets encoded outside of the O-antigen gene cluster is indicative of Shiga toxin-producing Escherichia coli serogroup lineages.

Authors:  Matthew W Gilmour; Adam B Olson; Ashleigh K Andrysiak; Lai-King Ng; Linda Chui
Journal:  J Med Microbiol       Date:  2007-05       Impact factor: 2.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.